2nd Quarter - Report
ARDELYX, INC. for ARDELYX, INC.
Firm
Client
Income
—
Expenses
$540,000
Expense method
A: Lobbying Disclosure Act definitions
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
H.R.5074, S.4510, Kidney Patient Act, Kidney Health Equity. Access to Innovative Kidney Treatments.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MATTHEW LASH | — |
| PAUL PEREIRA | — |
Medicare/Medicaid MMM
Medicaid rebate, most favored nation drug pricing. Increase Access to Innovation for People with Kidney Failure. Support Medicare Part D access to phosphorus-lowering medications.
| Lobbyist | Covered position, as disclosed |
|---|---|
| THERESA JOLIVETTE New | — |
| ZACHARY KRIBS | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.